# Grace Therapeutics, Inc.: Form 8-K, filed Sep 18, 2026

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 8-K
- Filed: 2026-09-18
- Accepted by EDGAR: Sep 18, 2026, 16:06 ET
- Period: 2026-09-17
- Accession: 0001140361-26-037114
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000114036126037114/ef20082416_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000114036126037114/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000114036126037114/ef20082416_8k.htm

Filed Sep 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-037114. Last ingested by Listed: Nov 14, 2026, 23:10 ET. No prices; not investment advice.
